Related Experiment Video

Updated: May 12, 2026

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

Adverse drug event prevention in neonatal care: a rule-based approach

Katerina Lazou1, Maria Farini, Vassilis Koutkias

  • 1Aristotle University, Thessaloniki, Greece. klazou@med.auth.gr

Studies in Health Technology and Informatics
|April 2, 2013
PubMed

Insights

This study developed a knowledge base to identify and prevent adverse drug events (ADEs) in neonatal intensive care units. The system uses an ontological model and 164 rules to simulate ADE prevention strategies for vulnerable neonates.

Area of Science:

  • Neonatal pharmacology
  • Clinical informatics
  • Knowledge engineering

Background:

  • Adverse drug events (ADEs) pose significant risks in neonatal units due to patient vulnerability.
  • Effective identification and prevention strategies for ADEs are crucial for neonatal patient safety.

Purpose of the Study:

  • To develop a knowledge base (KB) for supporting the identification and prevention of ADEs in a neonatal unit.
  • To create a system that can represent and simulate ADE prevention procedures.

Main Methods:

  • Conducted a literature review to identify ADEs associated with common neonatal drugs.
  • Developed an ontological data model for representing neonatal-specific drug event information.
  • Implemented a rule-based prototype with 164 rules for simulating ADE prevention.

Main Results:

  • Successfully developed a KB encoding knowledge about neonatal ADEs.
  • Created a functional rule-based prototype capable of simulating ADE prevention inferences.
  • The system is designed to support the specific needs of a neonatal unit.

Conclusions:

  • The developed knowledge base and rule-based system offer a promising approach for identifying and preventing ADEs in neonates.
  • This work contributes to improving patient safety in neonatal intensive care settings through advanced informatics.
  • The ontological model and rule-based simulation provide a framework for proactive ADE management.

More Related Videos

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Related Concept Videos

Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...